Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.30) by 20 percent. This is a 14.29 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $45.376 million which beat the analyst consensus estimate of $44.020 million by 3.08 percent. This is a 4.24 percent decrease over sales of $47.387 million the same period last year.